Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21806Phase 4Recruiting
Phase 4, randomised, open-label trial of corticosteroids in atopic dermatitis (AD) (2 arms), sponsored by Havenziekenhuis. Primary endpoint: Change in objective SCORAD. Started Feb 2009; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21806.